Pharmacokinetics of reboxetine in elderly patients with depressive disorders

International Journal of Clinical Pharmacology and Therapeutics

Volumn 38, Issue 5, 2000, Pages 254-259

  Poggesi, I ^a   Pellizzoni, C ^a   Fleishaker, J C ^a  

^a PFIZER INC   (United States)

Author keywords

Elderly; Pharmacokinetics; Reboxetine; Selective norepinephrine reuptake inhibitor

Indexed keywords

REBOXETINE;

AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DEPRESSION; DOSE RESPONSE; DRUG BLOOD LEVEL; FEMALE; HUMAN;

EID: 0034060866     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP38254     Document Type: Article

References (20)

1. American Psychiatric Association 1987 Diagnostic and Statistical Manual of Mental Disorders (3rd ed revised). American Psychiatric Association, Washington DC
2. Andreoli V, Pellizzoni C, Jannuzzo MG, Poggesi I 1999 Reboxetine in the treatment of depression in the elderly: a pilot study. J Geriatr Psychiatry Neurol 12: 206-210
3. Dostert P, Benedetti MS, Poggesi I 1997 Review of pharmacokinetics and metabolism of reboxetine, a selective noradrenaline reuptake inhibitor. Eur Neuropsychopharmacol 7: S23-S35
4. Dunner DL 1992 Diagnostic and treatment considerations in the depressed elderly patient. Adv Ther 9: 350-359
5. Edwards DMF, Pellizzoni C, Breuel HP, Berardi A, Castelli MG, Frigerio E, Poggesi I, Rocchetti M, Dubini A, Strolin Benedetti M 1995 Pharmacokinetics of reboxetine in healthy volunteers: single oral doses, linearity and plasma protein binding. Biopharm Drug Dispos 16: 443-460
6. Finkel SI 1996 Efficacy and tolerability of antidepressant therapy in the old-old. J Clin Psychiatry 57 (Suppl 5): 23-28
7. Folstein MF, Folstein SE, McHugh PR 1975 Mini-Mental State: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189-198
8. Herman BD, Fleishaker JC, Brown MC 1999 Ketoconazole inhibits the clearance of the enantiomers of the antidepressant reboxetine in humans. Clin Pharmacol Ther 66: 374-379
9. Jannuzzo MG, Strolin Benedetti M, Duchene P, Dubini A, Dostert P 1994 Pharmacokinetics of reboxetine in the elderly. Advances in simultaneous pharmacokinetic/pharmacodynamic modelling (abstract). 2nd International Symposium. Measurement and Kinetics of In Vivo Drug Effects. Noordwijkerhout, The Netherlands, pp 94-96
10. Jannuzzo MG, Ryde M, Karlmark B, Ronn O, Pellizzoni C, Poggesi I, Rocchetti M, Frigerio E, Dostert P, Strolin Benedetti M 1995 Pharmacokinetics of reboxetine in healthy volunteers of different ages (abstract). Eur Neuropsychopharmacol 5: 300
11. Lebowitz BD, Pearson JL, Schneider LS, Reynolds III CF, Alexopoulos GS, Bruce ML, Conwell Y, Katz IR, Meyers BS, Morrison MF, Mossey J, Niederehe G, Parmelee P 1997 Diagnosis and treatment of depression in late life. Consensus statement update. JAMA 278: 1186-1190
12. Lindeman RD 1992 Changes in renal function with aging: implications for treatment. Drugs Aging 2: 423-431
13. Montgomery SA 1997 Reboxetine: additional benefits to the depressed patient. J Psychopharmacol 11 (Suppl): S9-S15
14. Mucci M 1997 Reboxetine: a review of antidepressant tolerability. J Psychopharmacol 11 (Suppl): S33-S37
15. NIH Consensus Development Panel on Depression in Later Life 1991 Diagnosis and treatment of depression in later life. JAMA 268: 1018-1024
16. Pellizzoni C, Poggesi I, Jørgensen NP, Edwards DMF, Paus E, Strolin Benedetti M 1996 Pharmacokinetics of reboxetine in healthy volunteers: single against repeated oral doses and lack of enzymatic alterations. Biopharm Drug Dispos 17: 623-633
17. Preskorn SH 1993 Recent pharmacologic advances in antidepressant therapy for the elderly. Am J Med 94 (Suppl 5A): 2S-12S
18. Volz H-P, Möller J 1994 Antidepressant drug therapy in the elderly - a critical review of the controlled clinical trials conducted since 1980. Pharmacopsychiatry 27: 93-100
19. Woodhouse KW, Wynne H, Baillie S, James OFW, Rawlins MD 1988 Who are the frail elderly? Q J Med 68: 505-506
20. Wynalda MA, Grossi P, Speed W, Howard MR Hauer MJ, Wienkers LC 1998 Cytochrome P-450-mediated metabolism of the individual enantiomers of the antidepressant agent reboxetine in human liver microsomes. Pharm Sci 1: 5-40 (abstract)